scholarly journals Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?

2014 ◽  
Vol 8 (11-12) ◽  
pp. 762 ◽  
Author(s):  
Mai Ahmed Banakhar ◽  
Yahya Gazwani ◽  
Mohamed ElKelini ◽  
Tariq Al-shaiji ◽  
Magdy Hassouna

Introduction: Sacral neuromodulation (SNM) has become an established therapy for voiding dysfunction. Additional benefits, such as improved bowel functions and bladder pain, have been reported. Improvement in female sexual function after SNM treatment has been suggested; however, reports examining the effects of SNM on female sexual functions are scarce. We evaluate the effects of SNM on female sexual function and its impact on quality of life and analyze any correlation.Methods: Data were collected from January 2010 to May 2012 for all female patients who underwent SNM InterStim (Medtronic, Minneapolis, MN) therapy at a single centre in Canada. They were treated for voiding dysfunction, including refractory overactive bladder, frequency-urgency syndrome and non-obstructive urinary retention. Patients were screened by percutaneous nerve evaluation (PNE) to assess their response to therapy using a 4-day voiding diary. Patients who experienced 50% or more improvement in their voiding parameters were permanently implanted. All patients completed the Female Sexual Function Index (FSFI), Short-Form Health Survey (SF-36), and incontinence questionnaires (Urinary Distress Inventory [UDI]-6) preoperatively and 4 months postoperatively.Results: A total of 33 female patients had SNM therapy; 10 were excluded from the study because they were not sexually active. The indications were: refractory overactive bladder in 19, frequency urgency syndrome in 2, and non-obstructive urinary retention in another 2 patients. SNM therapy significantly improved the total FSFI score (p = 0.011); the components of desire and orgasm showed significant improvement (p = 0.014 and p = 0.035, respectively). Age, body mass index, diagnosis, and urinary symptoms did not show significant correlation with FSFI score improvement. Quality of life showed significant improvement after SNM treatment in 5 categories. There was no correlation between improvement in quality of life and FSFI.Conclusion: SNM may improve female sexual function and quality of life, yet there is no correlation between the improvement in FSFI and quality of life. 

2011 ◽  
Vol 8 (4) ◽  
pp. 1147-1155 ◽  
Author(s):  
Diego Signorello ◽  
Carl Christian Seitz ◽  
Lucas Berner ◽  
Emanuela Trenti ◽  
Thomas Martini ◽  
...  

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Mai Banakhar ◽  
Yahya Gazwani ◽  
Mohamed ElKelini ◽  
Tariq Al-shaiji ◽  
Magdy Hassouna

2017 ◽  
Vol 23 (14) ◽  
pp. 1769-1780 ◽  
Author(s):  
Ebru Gozuyesil ◽  
Sule Gokyildiz Surucu ◽  
Sultan Alan

This study aims to evaluate the relationship between the sexual functions and quality of life and the problems during menopausal period. This descriptive, cross-sectional study included a total of 317 women. The mean total Female Sexual Function Index score was 18.8 ± 8.7, while the mean total Sexual Quality of Life Questionnaire-Female score was 72.7 ± 13.7. Sexual dysfunction was found in 82 percent. There was a positive significant correlation between the total Female Sexual Function Index scores and total Sexual Quality of Life Questionnaire-Female scores ( p < 0.05). Our study results suggest that women do not often experience serious menopausal symptoms, but have sexual dysfunction with a moderate sexual quality of life.


2013 ◽  
Vol 16 (3) ◽  
pp. A77
Author(s):  
M. Hock ◽  
S. Tóth ◽  
G. Hartmann ◽  
B. Hajnal ◽  
J. Kránicz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document